CRNC vs EXAS · rev $251.8M vs rev $2.76B
Cerence Inc (CRNC) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Cerence Inc (CRNC) is a software - application company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported CRNC revenue for 2025-09-30 was $251.8M. Net income was -$18.7M. CRNC currently screens at market cap $460.7M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
CRNC currently screens at market cap $460.7M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the CRNC and EXAS stock pages for the full models.
Not investment advice.